Join
Live feed
·
PRReleasevia Quantisnow
Regulus Therapeutics Inc. logo

Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors

ByQuantisnow·Wall Street's wire, on your screen.
RGLS· Regulus Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RGLS (Regulus Therapeutics Inc.) and more on Quantisnow.